Monte Rosa Therapeutics Inc (GLUE)
8.48
-0.15
(-1.74%)
USD |
NASDAQ |
Nov 14, 16:00
8.48
0.00 (0.00%)
After-Hours: 05:34
Monte Rosa Therapeutics Profit Margin (Quarterly): -645.6% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -645.6% |
| Date | Value |
|---|---|
| March 31, 2024 | -3.00K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.00K%
Minimum
Mar 2024
-645.6%
Maximum
Jun 2024
-1.83K%
Average
-1.83K%
Median
Profit Margin (Quarterly) Benchmarks
| Novartis AG | 24.21% |
| MEI Pharma Inc | -- |
| Evoke Pharma Inc | -49.45% |
| Revance Therapeutics Inc | -63.65% |
| Vera Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Operating Margin (Quarterly) | -695.3% |